Circulating Plasma Cells at the Time of Collection of Autologous PBSC for Transplant in Multiple Myeloma Patients is a Negative Prognostic Factor Even in the Age of Post-Transplant Maintenance Therapy.

@article{Cowan2018CirculatingPC,
  title={Circulating Plasma Cells at the Time of Collection of Autologous PBSC for Transplant in Multiple Myeloma Patients is a Negative Prognostic Factor Even in the Age of Post-Transplant Maintenance Therapy.},
  author={Andrew J Cowan and Philip A Stevenson and Edward N. Libby and Pamela S Becker and David G Coffey and Damian J Green and Teresa S Hyun and Jonathan R. Fromm and Ajay K. Gopal and Leona A Holmberg},
  journal={Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation},
  year={2018},
  volume={24 7},
  pages={
          1386-1391
        }
}
Circulating plasma cells (CPCs) have been detected in patients with multiple myeloma (MM) at various stages of disease and associated with worse outcomes. Little data exist regarding the impact of CPCs at the time of autologous peripheral blood stem cell (PBSC) collection on outcomes, and the impact of maintenance therapy after autologous stem cell… CONTINUE READING